ImmunoPrecise Antibodies Ltd. (IPA)
| Previous close | 6.36 |
| Open | 6.25 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 3200 |
| Day's range | 6.09 - 6.32 |
| 52-week range | 5.05 - 33.34 |
| Volume | 50,702 |
| Avg. volume | 297,176 |
| Market cap | 121.146M |
| Beta (5Y monthly) | -0.16 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.46 |
| Earnings date | 20 Dec 2021 - 24 Dec 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
ImmunoPrecise Announces At-The-Market Facility of up to US$50 Million
VICTORIA, British Columbia, October 13, 2021--IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA), a leader in full-service therapeutic antibody discovery and development, today announced that it has entered into an At-The-Market Distribution Agreement (the "ATM Agreement") with H.C. Wainwright & Co., LLC, as sole sales agent (the "Agent"). Under the ATM Agreement, the Company will be entitled, at its discretion and from time-to-time during the term of the ATM
- Business Wire
Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration With Pierre Fabre
VICTORIA, British Columbia & CASTRES, France, October 07, 2021--IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) and the Pierre Fabre pharmaceutical group announced today that IPA’s subsidiary, Talem Therapeutics LLC ("Talem"), and Pierre Fabre have entered a multi-year, multi-target research collaboration with the goal to discover and develop therapeutics antibodies for up to nine targets. This strategic collaboration is expected to help expand Talem’s por
- Business Wire
ImmunoPrecise Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2022
VICTORIA, British Columbia, September 09, 2021--IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA), a leader in full-service therapeutic antibody discovery and development, today announced financial results for first quarter fiscal year 2022, which ended July 31, 2021.
